Cargando…
Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France
OBJECTIVE: Our objectives were to describe the basal insulin treatment regimens most widely used in a real-world setting in France and to estimate the associated treatment costs in people with type 2 diabetes mellitus (T2DM). METHODS: A cross-sectional observational study was conducted (November 201...
Autores principales: | Detournay, Bruno, Boultif, Zahra, Bahloul, Amar, Jeanbat, Viviane, Robert, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160062/ https://www.ncbi.nlm.nih.gov/pubmed/33215332 http://dx.doi.org/10.1007/s41669-020-00237-4 |
Ejemplares similares
-
Persistence with Basal Insulin and Frequency of Hypoglycemia Requiring Hospitalization in Patients with Type 2 Diabetes
por: Roussel, Ronan, et al.
Publicado: (2020) -
Efficacy and Safety of Switching Patients Inadequately Controlled on Basal Insulin to Insulin Glargine 300 U/mL: The TRANSITION 2 Study
por: Gourdy, Pierre, et al.
Publicado: (2019) -
The Effectiveness of an App (Insulia) in Recommending Basal Insulin Doses for French Patients With Type 2 Diabetes Mellitus: Longitudinal Observational Study
por: Nevoret, Camille, et al.
Publicado: (2023) -
Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study
por: Roussel, Ronan, et al.
Publicado: (2016) -
Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
por: Shafie, Asrul Akmal, et al.
Publicado: (2020)